AnnJi Pharmaceutical Co., Ltd. (AnnJi, TPEx: 7754), a clinical-stage drug development company focused on innovative small molecules, today announced that it is proceeding with the U.S. portion of its ...
Kensington, MD, USA, and Munich/Martinsried, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Data presented at EURETINA 2026 ...
The phase 2 ArMaDa results showed that one subretinal injection of medium-dose OCU410, an investigational adeno-associated ...
A year after receiving a Prima implant, more than half of patients with geographic atrophy were able to complete tasks such as reading books and using digital devices, according to a study presented ...
Geographic atrophy (GA) is a condition that typically progresses slowly, with lesions expanding by about 1 square millimeter per year, leading to blind spots due to retinal deterioration. Treatment ...
Geographic atrophy (GA) is an advanced form of dry macular degeneration that causes irreversible vision loss and affects daily activities such as reading, driving, and recognizing faces. Vision loss ...
Scholar Rock Holding (SRRK) surged 12% in extended trading Friday after the Food and Drug Administration approved isembyld, the company’s treatment for spinal muscular atrophy. Isembyld, also known as ...
Panel A shows how insulin and insulin-like growth factor-1 (IGF-1) effect protein anabolism by signaling through their receptors (IR and IGF1R, respectively). This signaling results in the activation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results